N


Journal

Current medical science
ISSN: 2523-899X
Titre abrégé: Curr Med Sci
Pays: China
ID NLM: 101729993

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 10 06 2020
revised: 02 07 2020
entrez: 19 7 2020
pubmed: 19 7 2020
medline: 19 5 2021
Statut: ppublish

Résumé

N

Identifiants

pubmed: 32681245
doi: 10.1007/s11596-020-2194-0
pii: 10.1007/s11596-020-2194-0
doi:

Substances chimiques

Carrier Proteins 0
RNA 63231-63-0
N-methyladenosine CLE6G00625
Methyltransferases EC 2.1.1.-
Adenosine K72T3FS567

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

401-406

Références

Ng RK, Gurdon JB. Epigenetic inheritance of cell differentiation status. Cell Cycle, 2008, 7(9):1173–1177
pubmed: 18418041
Roundtree IA, Evans ME, Pan T. Dynamic RNA Modifications in Gene Expression Regulation. Cell, 2017, 169(7):1187–1200
pubmed: 5657247 pmcid: 5657247
Aguilo F, Walsh MJ. The N(6)-Methyladenosine RNA modification in pluripotency and reprogramming. Curr Opin Genet Dev, 2017, 46:77–82
pubmed: 28683341 pmcid: 5626584
Gilbert WV, Bell TA. Schaening C: Messenger RNA modifications: Form, distribution, and function Science, 2016,352(6292):1408–1412
pubmed: 5094196 pmcid: 5094196
Wei CM, Moss B. Nucleotide sequences at the N6-methyladenosine sites of HeLa cell messenger ribonucleic acid. Biochemistry, 1977, 16(8):1672–1676
pubmed: 856255
Schibler U, Kelley DE, Perry RP. Comparison of methylated sequences in messenger RNA and heterogeneous nuclear RNA from mouse L cells. J Mol Biol, 1977, 115(4):695–714
pubmed: 592376
Beemon K, Keith J. Localization ofN6-methyladenosine in the Rous sarcoma virus genome. J Mol Biol 1977,113(1):165–179
pubmed: 196091
Rottman FM, Desrosiers RC, Friderici K. Nucleotide methylation patterns in eukaryotic mRNA. Prog Nucleic Acid Res Mol Biol, 1976, 19:21–38
pubmed: 190642
Krug RM, Morgan MA, Shatkin AJ. Influenza viral mRNA contains internal N6-methyladenosine and 5′-terminal 7-methylguanosine in cap structures. J Virol, 1976, 20(1):45–53
pubmed: 1086370 pmcid: 354964
Fu Y, Dominissini D, Rechavi G, He C. Gene expression regulation mediated through reversible m(6)A RNA methylation. Nat Rev Genet, 2014, 15(5):293–306
pubmed: 24662220
Patil DP, Pickering BF, Jaffrey SR. Reading m(6)A in the Transcriptome: m(6)A-Binding Proteins. Trends Cell Biol, 2018, 28(2):113–127
pubmed: 29103884
Meyer KD, Jaffrey SR. Rethinking m(6)A Readers, Writers, and Erasers. Annu Rev Cell Dev Biol,2017, 33:319–342
pubmed: 28759256 pmcid: 5963928
Shi H, Zhang X, Weng YL, et al. m(6)A facilitates hippocampus-dependent learning and memory through YTHDF1. Nature, 2018, 563(7730):249–253
pubmed: 30401835 pmcid: 6226095
Wang CX, Cui GS, Liu X, et al. METTL3-mediated m6A modification is required for cerebellar development PLoS Biol, 2018,16(6):e2004880
pubmed: 29879109 pmcid: 6021109
Chen M, Wong CM. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis. Mol Cancer, 2020, 19(1):44
pubmed: 32111216 pmcid: 7047367
Chen RX, Chen X, Xia LP, et al. N(6)-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat Commun, 2019, 10(1):4695
pubmed: 31619685 pmcid: 6795808
Berulava T, Buchholz E, Elerdashvili V, et al. Changes in m6A RNA methylation contribute to heart failure progression by modulating translation. Eur J Heart Fail, 2020, 22(1):54–66
pubmed: 31849158
Mathiyalagan P, Adamiak M, Mayourian J, et al. FTO-Dependent N(6)-Methyladenosine Regulates Cardiac Function During Remodeling and Repair. Circulation 2019,139(4):518–532
pubmed: 29997116 pmcid: 6400591
Zhou P, Wu M, Ye C, et al. Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m(6)A abrogation in RNA. J Biol Chem, 2019, 294(45):16908–16917
pubmed: 31578283 pmcid: 6851328
Xu Y, Yuan XD, Wu JJ, et al. The N6-methyladenosine mRNA methylase METTL14 promotes renal ischemic reperfusion injury via suppressing YAP1. J Cell Biochem, 2020, 121(1):524–533
pubmed: 31318098
Meyer KD, Saletore Y, Zumbo P, et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3′UTRs and near stop codons. Cell, 2012, 149(7):1635–1646
pubmed: 22608085 pmcid: 3383396
Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother, 2019, 112:108613
pubmed: 30784918
Wang X, Feng J, Xue Y, et al. Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex. Nature, 2016, 534(7608):575–578
pubmed: 27281194
Wang P, Doxtader KA, Nam Y. Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. Mol Cell, 2016, 63(2):306–317
pubmed: 27373337 pmcid: 4958592
Sledz P, Jinek M. Structural insights into the molecular mechanism of the m(6)A writer complex. Elife, 2016, 5:e18434
pubmed: 27627798 pmcid: 5023411
Liu J, Yue Y, Han D, et al. A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol, 2014, 10(2):93–95
pubmed: 24316715
Ping XL, Sun BF, Wang L, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase. Cell Res, 2014, 24(2):177–189
pubmed: 24407421 pmcid: 24407421
Pendleton KE, Chen B, Liu K, et al. The U6 snRNA m(6)A Methyltransferase METTL16 Regulates SAM Synthetase Intron Retention. Cell, 2017, 169(5):824–835
pubmed: 28525753 pmcid: 5502809
Schwartz S, Mumbach MR, Jovanovic M, et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5′ sites. Cell Rep, 2014, 8(1):284–296
pubmed: 24981863 pmcid: 4142486
Patil DP, Chen CK, Pickering BF, et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature, 2016, 537(7620):369–373
pubmed: 27602518 pmcid: 5509218
Wen J, Lv R, Ma H, et al. Zc3h13 Regulates Nuclear RNA m(6)A Methylation and Mouse Embryonic Stem Cell Self-Renewal. Mol Cell, 2018, 69(6):1028–1038
pubmed: 29547716 pmcid: 5858226
Yue Y, Liu J, Cui X, et al. VIRMA mediates preferential m(6)A mRNA methylation in 3′UTR and near stop codon and associates with alternative polyadenylation. Cell Discov, 2018, 4:10
pubmed: 29507755 pmcid: 5826926
van Tran N, Ernst FGM, Hawley BR, et al. The human 18S rRNA m6A methyltransferase METTL5 is stabilized by TRMT112. Nucleic Acids Res, 2019, 47(15):7719–7733
pubmed: 31328227 pmcid: 6735865
Ma H, Wang X, Cai J, et al. N(6-)Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation. Nat Chem Biol, 2019, 15(1):88–94
pubmed: 30531910
Yang Y, Hsu PJ, Chen YS, et al. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res, 2018, 28(6):616–624
pubmed: 29789545 pmcid: 5993786
Ueda Y, Ooshio I, Fusamae Y, et al. AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells. Sci Rep, 2017, 7:42271
pubmed: 28205560 pmcid: 5304225
Wang L, Wen M, Cao X. Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses. Science, 2019, 365(6454):eaav0758
Peng S, Xiao W, Ju D, et al. Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1. Sci Transl Med, 2019, 11(488):eaau7116
pubmed: 30996080
Chen J, Fang X, Zhong P, et al. N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction. RNA Biol, 2019, 16(8):991–1000
pubmed: 31107151 pmcid: 6602412
Alarcon CR, Goodarzi H, Lee H, et al. HNRNPA2B1 Is a Mediator of m(6)A-Dependent Nuclear RNA Processing Events. Cell, 2015, 162(6):1299–1308
pubmed: 26321680 pmcid: 26321680
Liu N, Dai Q, Zheng G, et al. N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature, 2015, 518(7540):560–564
pubmed: 25719671 pmcid: 25719671
Liu N, Zhou KI, Parisien M, et al. N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein. Nucleic Acids Res, 2017,45(10): 6051–6063
pubmed: 28334903 pmcid: 5449601
Huang H, Weng H, Sun W, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol, 2018, 20(3):285–295
pubmed: 29476152 pmcid: 5826585
Hess ME, Hess S, Meyer KD, et al. The fat mass and obesity associated gene (Fto) regulates activity of the dopaminergic midbrain circuitry. Nat Neurosci, 2013, 16(8):1042–1048
pubmed: 23817550
Chang M, Lv H, Zhang W, et al. Region-specific RNA m(6)A methylation represents a new layer of control in the gene regulatory network in the mouse brain. Open Biol, 2017, 7(9):170166
pubmed: 28931651 pmcid: 5627058
Engel M, Eggert C, Kaplick PM, et al. The Role of m(6) A/m-RNA Methylation in Stress Response Regulation. Neuron, 2018, 99(2):389–403
pubmed: 30048615 pmcid: 6069762
Ma C, Chang M, Lv H, et al. RNA m(6)A methylation participates in regulation of postnatal development of the mouse cerebellum. Genome Biol, 2018, 19(1):68
pubmed: 29855379 pmcid: 5984455
Frye M, Harada BT, Behm M, et al. RNA modifications modulate gene expression during development. Science, 2018, 361(6409):1346–1349
pubmed: 30262497 pmcid: 6436390
Li L, Zang L, Zhang F, et al. Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis. Hum Mol Genet, 2017, 26(13):2398–2411
pubmed: 28398475 pmcid: 6192412
Weng YL, Wang X, An R, et al. Epitranscriptomic m(6)A Regulation of Axon Regeneration in the Adult Mammalian Nervous System. Neuron, 2018, 97(2):313–325
pubmed: 29346752 pmcid: 5777326
Holt CE, Martin KC, Schuman EM. Local translation in neurons: visualization and function. Nat Struct Mol Biol, 2019, 26(7):557–566
pubmed: 31270476
Yu J, Chen M, Huang H, et al. Dynamic m6A modification regulates local translation of mRNA in axons. Nucleic Acids Res, 2018, 46(3):1412–1423
pubmed: 29186567
Widagdo J, Zhao QY, Kempen MJ, et al. Experience-Dependent Accumulation of N6-Methyladenosine in the Prefrontal Cortex Is Associated with Memory Processes in Mice. J Neurosci, 2016, 36(25):6771–6777
pubmed: 27335407 pmcid: 4916251
Walters BJ, Mercaldo V, Gillon CJ, et al. The Role of The RNA Demethylase FTO (Fat Mass and Obesity-Associated) and mRNA Methylation in Hippocampal Memory Formation. Neuropsychopharmacology, 2017, 42(7):1502–1510
pubmed: 28205605 pmcid: 5436121
Zhang Z, Wang M, Xie D, et al. METTL3-mediated N(6)-methyladenosine mRNA modification enhances long-term memory consolidation. Cell Res, 2018,28(11): 1050–1061
pubmed: 30297870 pmcid: 6218447
Chai RC, Wu F, Wang QX, et al. m(6)ARNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas. Aging, 2019, 11(4):1204–1225
pubmed: 30810537 pmcid: 6402513
Cui Q, Shi H, Ye P, et al. m(6)A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells. Cell Rep, 2017, 18(11):2622–2634
pubmed: 28297667 pmcid: 5479356
Visvanathan A, Patil V, Arora A, et al. Essential role of METTL3-mediated m(6)A modification in glioma stemlike cells maintenance and radioresistance. Oncogene, 2018, 37(4):522–533
pubmed: 28991227
Zhang S, Zhao BS, Zhou A, et al. m(6)A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. Cancer Cell, 2017,31(4): 591–606
pubmed: 28344040 pmcid: 5427719
Du T, Rao S, Wu L, et al. An association study of the m6A genes with major depressive disorder in Chinese Han population. J Affect Disord, 2015, 183:279–286
pubmed: 26047305
Milaneschi Y, Lamers F, Mbarek H, et al. The effect of FTO rs9939609 on major depression differs across MDD subtypes. Mol Psychiatry, 2014, 19(9):960–962
pubmed: 24492350
Samaan Z, Anand SS, Zhang X, et al. The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression. Mol Psychiatry, 2013, 18(12):1281–1286
pubmed: 23164817
Yao Y, Wen Y, Du T, et al. Meta-analysis indicates that SNP rs9939609 within FTO is not associated with major depressive disorder (MDD) in Asian population. J Affect Disord, 2016, 193:27–30
pubmed: 26766031
Dina C, Meyre D, Gallina S, et al: Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet, 2007,39(6):724–726
pubmed: 17496892
Sun L, Ma L, Zhang H, et al. Fto Deficiency Reduces Anxiety- and Depression-Like Behaviors in Mice via Alterations in Gut Microbiota. Theranostics, 2019, 9(3):721–733
pubmed: 30809304 pmcid: 6376469
Huang R, Zhang Y, Bai Y, et al. N(6)-Methyladenosine Modification of Fatty Acid Amide Hydrolase Messenger RNA in Circular RNA STAG1-Regulated Astrocyte Dysfunction and Depressive-like Behaviors. Biol Psychiatry, 2020, doi: https://doi.org/10.1016/j.biopsych.2020.02.018
Chokkalla AK, Mehta SL, Kim T, et al. Transient Focal Ischemia Significantly Alters the m(6)A Epitranscriptomic Tagging of RNAs in the Brain. Stroke, 2019, 50(10):2912–2921
pubmed: 31436138 pmcid: 6759411
Lane CA, Hardy J, Schott JM. Alzheimer’s disease. Eur J Neurol, 2018, 25(1):59–70
pubmed: 28872215 pmcid: 28872215
Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med, 2012, 367(9):795–804
pubmed: 22784036 pmcid: 3474597
Han M, Liu Z, Xu Y, et al. Abnormality of m6A mRNA Methylation Is Involved in Alzheimer’s Disease. Front Neurosci, 2020, 14:98
pubmed: 32184705 pmcid: 7058666
Li H, Ren Y, Mao K, et al. FTO is involved in Alzheimer’s disease by targeting TSC1-mTOR-Tau signaling. Biochem Biophys Res Commun, 2018, 498(1):234–239
pubmed: 29501742
Chen X, Yu C, Guo M, et al. Down-Regulation of m6A mRNA Methylation Is Involved in Dopaminergic Neuronal Death. ACS Chem Neurosci, 2019, 10(5):2355–2363
pubmed: 30835997
Zhou C, Molinie B, Daneshvar K, et al. Genome-Wide Maps of m6A circRNAs Identify Widespread and Cell-Type-Specific Methylation Patterns that Are Distinct from mRNAs. Cell Rep, 2017, 20(9):2262–2276
pubmed: 28854373 pmcid: 5705222
Yang Y, Fan X, Mao M, et al. Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Res, 2017, 27(5):626–641
pubmed: 28281539 pmcid: 5520850
Alarcon CR, Lee H, Goodarzi H, et al. N6-methyladenosine marks primary microRNAs for processing. Nature, 2015, 519(7544):482–485
pubmed: 25799998 pmcid: 25799998

Auteurs

Bing Han (B)

Department of Pharmacology, School of Medicine, Southeast University, Nanjing, 210009, China.

Hong-Hong Yao (HH)

Department of Pharmacology, School of Medicine, Southeast University, Nanjing, 210009, China. yaohh@seu.edu.cn.
Institute of Life Sciences, Key Laboratory of Developmental Genes and Human Disease, Southeast University, Nanjing, 210009, China. yaohh@seu.edu.cn.
Co-innovation Center of Neuroregeneration, Nantong University, Nantong, 226019, China. yaohh@seu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH